Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Repligen Corp’s stock clocked out at $144.88, up 0.37% from its previous closing price of $144.34. In other words, the price has increased by $0.37 from its previous closing price. On the day, 0.73 million shares were traded. RGEN stock price reached its highest trading level at $146.6 during the session, while it also had its lowest trading level at $138.01.
Ratios:
To gain a deeper understanding of RGEN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 61.84. For the most recent quarter (mrq), Quick Ratio is recorded 8.76 and its Current Ratio is at 10.44. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on March 18, 2025, initiated with a In-line rating and assigned the stock a target price of $155.
On February 10, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $200.
On December 17, 2024, Canaccord Genuity started tracking the stock assigning a Hold rating and target price of $165.Canaccord Genuity initiated its Hold rating on December 17, 2024, with a $165 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Hunt Anthony sold 26,756 shares for $152.51 per share. The transaction valued at 4,080,663 led to the insider holds 136,301 shares of the business.
Pax Margaret bought 250 shares of RGEN for $37,672 on Mar 17 ’25. The Director now owns 1,043 shares after completing the transaction at $150.69 per share. On Mar 17 ’25, another insider, Hunt Anthony, who serves as the Director of the company, bought 26,756 shares for $150.42 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGEN now has a Market Capitalization of 8134809600 and an Enterprise Value of 8063694848. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.79 while its Price-to-Book (P/B) ratio in mrq is 4.02. Its current Enterprise Value per Revenue stands at 12.71 whereas that against EBITDA is 94.979.
Stock Price History:
The Beta on a monthly basis for RGEN is 1.21, which has changed by -0.27465707 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, RGEN has reached a high of $200.23, while it has fallen to a 52-week low of $113.50. The 50-Day Moving Average of the stock is -7.59%, while the 200-Day Moving Average is calculated to be -0.68%.
Shares Statistics:
It appears that RGEN traded 626.26K shares on average per day over the past three months and 829490 shares per day over the past ten days. A total of 56.03M shares are outstanding, with a floating share count of 52.91M. Insiders hold about 5.57% of the company’s shares, while institutions hold 100.98% stake in the company. Shares short for RGEN as of 1740700800 were 3453504 with a Short Ratio of 5.51, compared to 1738281600 on 3304952. Therefore, it implies a Short% of Shares Outstanding of 3453504 and a Short% of Float of 7.21.
